Humanity is a renowned brand in the field of genomics, precision medicine, and healthcare innovation. Led by Director Robert C. Green, MD, MPH, the brand is committed to accelerating the implementation of genomic medicine to improve health outcomes.

With a team of experts from Harvard Medical School, Brigham and Women's Hospital, and the Broad Institute, Humanity offers a wide range of products and services. Their research projects include the BabySeq Project, the PopSeq Project, the PGen Study, the MedSeq Project, and the MilSeq Project, among others. These projects involve randomized trials of sequencing in adults, newborns, and active duty military personnel, with the aim of demonstrating the feasibility of genomic sequencing and its potential medical benefits.

Notable achievements of the brand include leading the first experimental trials disclosing common complex disease risk and the first studies of direct-to-consumer genetic testing services. With continuous funding from NIH for 26 years, the brand has published over 400 papers and is a leader in the field. In addition to research, Humanity is actively involved in policy development, clinical care, and entrepreneurship.

Their Preventive Genomics Clinic offers evidence-based genomic evaluation to early adopters seeking to anticipate and prevent future illness. The brand has also launched Genome Medical, a telegenomics technology and services company providing genetics expertise to patients and healthcare systems. Humanity's Director, Dr.

Green, is internationally recognized for his contributions to the field and serves in various leadership positions, including co-chairing the Clinical Sequencing Exploratory Research program and the Newborn Sequencing in Genomic Medicine and Public Health program. He is also actively involved in policy efforts related to medical genomics, returning research information to participants, and managing incidental findings. With a commitment to precision medicine, Humanity is paving the way for the adoption of genomics in primary care.

Through their Precision Population Health initiative, they bring together experts and leaders to address the challenges in implementing precision medicine in healthcare systems. To support their groundbreaking research and initiatives, Humanity welcomes donations from those passionate about advancing the use of genomics in healthcare. Stay connected with their quarterly newsletter to stay informed about their latest findings and advancements.

In conclusion, Humanity is a leading brand in the field of genomics, precision medicine, and healthcare innovation. Their commitment to research, policy, clinical care, and entrepreneurship has made significant contributions to the field. With a team of experts, they strive to accelerate the implementation of genomic medicine to improve health outcomes